Carmen Bax

Title: Carmen Bax - Innovator in Prostate Cancer Risk Assessment

Introduction

Carmen Bax is a notable inventor based in Milan, Italy. She has made significant contributions to the field of medical diagnostics, particularly in assessing the risk of prostate cancer. Her innovative approach utilizes advanced technology to improve early detection and treatment strategies.

Latest Patents

Carmen Bax holds 1 patent for her groundbreaking work titled "Methods to assess the risk of being affected by prostate cancer." This patent discloses methods for evaluating the risk that a male subject may be affected by prostate cancer. It also includes techniques for determining the aggressiveness of such cancer by analyzing the gaseous headspace of urine samples using at least three metal oxide semiconductor-based gas sensors. The sensors include pure or doped SnO, pure or doped ZnO, and a combination of pure or doped SnO, TiO, and NbO.

Career Highlights

Throughout her career, Carmen has worked with esteemed organizations such as Humanitas Mirasole S.p.a. and Politecnico di Milano. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical technology.

Collaborations

Carmen has collaborated with notable professionals, including Gianluigi Taverna and Fabio Grizzi. These partnerships have enhanced her research and development efforts, leading to innovative solutions in cancer risk assessment.

Conclusion

Carmen Bax is a pioneering inventor whose work in prostate cancer risk assessment exemplifies the intersection of technology and healthcare. Her contributions are vital for improving patient outcomes and advancing medical diagnostics.